My first question has to be “has your lab animal had problems with hypoglycemia before?”
Secondly, studies have shown that the nature of MK2866 lowers the blood glucose level by 11% while simultaneously reducing insulin residence by 27%. Typically this shouldn’t develop into a problem, but for lab animals with prior hypoglycemic issues, this could lead to feeling light headed and fatigued. I would recommend using GW501516 and SR9009 until the condition is under control. You CAN use MK2866 in conjunction with blood sugar stabilizing medications.
Oxandrolone is a synthetic androstane steroid and a 17α-alkylated derivative of DHT.    It is also known as 2-oxa-17α-methyl-5α-dihydrotestosterone (2-oxa-17α-methyl-DHT) or as 2-oxa-17α-methyl-5α-androstan-17β-ol-3-one, and is DHT with a methyl group at the C17α position and the C2 carbon replaced with an oxygen atom.    Closely related AAS include the marketed AAS mestanolone (17α-methyl-DHT), oxymetholone (2-hydroxymethylene-17α-methyl-DHT), and stanozolol (a 2,3- pyrazole A ring -fused derivative of 17α-methyl-DHT) and the never-marketed/ designer AAS desoxymethyltestosterone (3-deketo-17α-methyl-δ 2 -DHT), methasterone (2α,17α-dimethyl-DHT), methyl-1-testosterone (17α-methyl-δ 1 -DHT), and methylstenbolone (2,17α-dimethyl-δ 1 -DHT).